{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:37:19Z","timestamp":1790807839250,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.anndiagpath.2018.10.006","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T13:56:18Z","timestamp":1539266178000},"page":"118-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Subclassification of pleomorphic sarcomas: How and why should we care?"],"prefix":"10.1016","volume":"37","author":[{"given":"Jason L.","family":"Hornick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0005","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1200\/JCO.2001.19.12.3045","article-title":"Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification","volume":"19","author":"Fletcher","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0010","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.ejso.2004.07.018","article-title":"Histopathological reclassification of extremity pleomorphic soft tissue sarcoma has clinical relevance","volume":"30","author":"Massi","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00000478-199602000-00001","article-title":"Pleomorphic soft tissue myogenic sarcomas of adulthood. A reappraisal in the mid-1990s","volume":"20","author":"Sch\u00fcrch","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/cncr.11617","article-title":"Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity: an analysis of 92 cases","volume":"98","author":"Deyrup","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0025","first-page":"127","article-title":"Myxofibrosarcoma. A study of 30 cases","volume":"85A","author":"Angervall","year":"1977","journal-title":"Acta Pathol Microbiol Scand A"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0030","first-page":"1","article-title":"Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis","volume":"282","author":"Merck","year":"1983","journal-title":"Acta Pathol Microbiol Immunol Scand Suppl"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000478-199604000-00001","article-title":"Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant","volume":"20","author":"Mentzel","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2559.2012.04348.x","article-title":"Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases","volume":"62","author":"Sioletic","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0045","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.humpath.2004.01.016","article-title":"Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems","volume":"35","author":"Huang","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1245\/s10434-012-2572-3","article-title":"Prognostic factors and outcomes of patients with myxofibrosarcoma","volume":"20","author":"Look Hong","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0055","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/jjco\/hyw199","article-title":"A histological positive margin after surgery is correlated with high local re-recurrence rate in patients with recurrent myxofibrosarcoma","volume":"47","author":"Kikuta","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0060","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijrobp.2018.05.055","article-title":"Localized myxofibrosarcomas: roles of surgical margins and adjuvant radiation therapy","volume":"102","author":"Boughzala-Bennadji","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.pas.0000213379.94547.e7","article-title":"Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases","volume":"31","author":"Nascimento","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/jso.24250","article-title":"Soft tissue myxofibrosarcoma: a clinico-pathological analysis of a series of 75 patients with emphasis on the epithelioid variant","volume":"114","author":"Scoccianti","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/modpathol.3800550","article-title":"Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model","volume":"19","author":"Willems","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0080","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00000478-200205000-00006","article-title":"Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group","volume":"26","author":"Gebhard","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0085","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/01.pas.0000135524.73447.4a","article-title":"Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases","volume":"28","author":"Hornick","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/modpathol.3880280","article-title":"Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases","volume":"14","author":"Downes","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0095","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1002\/cncr.26195","article-title":"Pleomorphic liposarcoma: clinical observations and molecular variables","volume":"117","author":"Ghadimi","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/his.12311","article-title":"Liposarcomas: diagnostic pitfalls and new insights","volume":"64","author":"Dei Tos","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0105","first-page":"722","article-title":"Epithelioid variant of pleomorphic liposarcoma: a study of 12 cases of a distinctive variant of high-grade liposarcoma","volume":"12","author":"Miettinen","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0110","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/1097-0142(19830215)51:4<727::AID-CNCR2820510429>3.0.CO;2-I","article-title":"Extraosseous osteosarcoma. A review of 48 patients","volume":"71","author":"Sordillo","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0115","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/1097-0142(19870901)60:5<1132::AID-CNCR2820600536>3.0.CO;2-L","article-title":"Extraskeletal osteosarcoma","volume":"60","author":"Chung","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0120","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/1097-0142(19951201)76:11<2253::AID-CNCR2820761112>3.0.CO;2-8","article-title":"A review of 40 patients with extraskeletal osteosarcoma","volume":"76","author":"Lee","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0125","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/00000478-199805000-00010","article-title":"Extraskeletal osteosarcoma: a clinicopathologic study of 25 cases","volume":"22","author":"Lidang Jensen","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0130","first-page":"2129","article-title":"Extraskeletal osteosarcoma in Norway, between 1975 and 2009, and a brief review of the literature","volume":"35","author":"Berner","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0135","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00432-005-0687-7","article-title":"Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma","volume":"131","author":"Goldstein-Jackson","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/his.12138","article-title":"SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours","volume":"63","author":"Conner","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0145","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00000478-199306000-00008","article-title":"Pleomorphic rhabdomyosarcoma in adulthood: analysis of 11 cases with definition of diagnostic criteria","volume":"17","author":"Gaffney","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0150","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/modpathol.3880357","article-title":"Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers","volume":"14","author":"Furlong","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0155","first-page":"6213","article-title":"Adult pleomorphic rhabdomyosarcoma: a multicentre retrospective study","volume":"35","author":"Noujaim","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0160","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/00000478-200108000-00007","article-title":"Pleomorphic leiomyosarcoma: a clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma","volume":"25","author":"Oda","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.humpath.2009.10.005","article-title":"Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases","volume":"41","author":"Nicolas","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0170","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1002\/cncr.26590","article-title":"Sarcoma metastases to the skin: a clinicopathologic study of 65 patients","volume":"118","author":"Wang","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0175","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/00000478-199412000-00004","article-title":"Dedifferentiated liposarcoma: a clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas","volume":"18","author":"McCormick","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0180","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00000478-199703000-00002","article-title":"Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation","volume":"21","author":"Henricks","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAS.0000000000000131","article-title":"Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?","volume":"38","author":"Le Guellec","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0190","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jamcollsurg.2013.10.009","article-title":"Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery","volume":"218","author":"Keung","year":"2014","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0195","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAS.0000000000000366","article-title":"Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma","volume":"39","author":"Gronchi","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0200","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.humpath.2017.02.015","article-title":"Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas","volume":"66","author":"Dantey","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0205","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/SLA.0000000000001149","article-title":"Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma","volume":"263","author":"Tan","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0210","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/PAS.0000000000000910","article-title":"Dedifferentiated liposarcoma with epithelioid\/epithelial features","volume":"41","author":"Makise","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0215","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/00000478-199411000-00009","article-title":"Heterologous elements in the dedifferentiated component of dedifferentiated liposarcoma","volume":"18","author":"Evans","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0220","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/PAS.0b013e3181e5dc49","article-title":"Dedifferentiated liposarcoma with \u201chomologous\u201d lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria","volume":"34","author":"Mari\u00f1o-Enr\u00edquez","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0225","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/PAS.0b013e3181dbf2f7","article-title":"Liposarcomas with mixed well-differentiated and pleomorphic features: a clinicopathologic study of 12 cases","volume":"34","author":"Boland","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0230","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/(SICI)1096-9896(200004)190:5<531::AID-PATH579>3.0.CO;2-W","article-title":"Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours","volume":"190","author":"Dei Tos","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0235","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1097\/PAS.0b013e3180581fff","article-title":"Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR","volume":"31","author":"Sirvent","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0240","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/01.pas.0000170343.09562.39","article-title":"MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data","volume":"29","author":"Binh","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0245","doi-asserted-by":"crossref","first-page":"812089","DOI":"10.1155\/2015\/812089","article-title":"Fluorescence in situ hybridization for MDM2 amplification as a routine ancillary diagnostic tool for suspected well-differentiated and dedifferentiated liposarcomas: experience at a tertiary center","volume":"2015","author":"Thway","year":"2015","journal-title":"Sarcoma"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0250","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/PAS.0000000000001014","article-title":"Clarifying the distinction between malignant peripheral nerve sheath tumor and dedifferentiated liposarcoma: a critical reappraisal of the diagnostic utility of MDM2 and H3K27me3 status","volume":"42","author":"Makise","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2559.2005.02289.x","article-title":"Classification of pleomorphic sarcomas: where are we now?","volume":"48","author":"Dei Tos","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2018.10.006_bb0260","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2017.75.3467","article-title":"Biology and management of undifferentiated pleomorphic sarcoma, myxofibrosarcoma, and malignant peripheral nerve sheath tumors: state of the art and perspectives","volume":"36","author":"Widemann","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913418303216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913418303216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:30:24Z","timestamp":1761078624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913418303216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":52,"alternative-id":["S1092913418303216"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2018.10.006","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subclassification of pleomorphic sarcomas: How and why should we care?","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2018.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}